D. Malcolm Duckworth

890 total citations
19 papers, 611 citations indexed

About

D. Malcolm Duckworth is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, D. Malcolm Duckworth has authored 19 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in D. Malcolm Duckworth's work include Pharmacological Receptor Mechanisms and Effects (3 papers), Receptor Mechanisms and Signaling (3 papers) and Chemical synthesis and alkaloids (3 papers). D. Malcolm Duckworth is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (3 papers), Receptor Mechanisms and Signaling (3 papers) and Chemical synthesis and alkaloids (3 papers). D. Malcolm Duckworth collaborates with scholars based in United Kingdom, United States and France. D. Malcolm Duckworth's co-authors include Frank D. King, Steven Dabbs, Ian T. Forbes, Graham J. Riley, Derek N. Middlemiss, Jim J. Hagan, A.J. Jennings, David R. Thomas, Peter J. Lovell and Steven M. Bromidge and has published in prestigious journals such as The Journal of Physiology, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

D. Malcolm Duckworth

19 papers receiving 578 citations

Peers

D. Malcolm Duckworth

CMN

PHYSI

CTM

Isabelle Berque‐Bestel France

Vilma Ruperto United States

Michel Langlois France

Elizabeth A. Harley United States

Pascal Rigollier Switzerland

Piero Angeli Italy

Abd M. Ismaiel United States

Anthony M. Brown United States

Sigrun Leonhardt United States

Blair Weig United States

Isabelle Berque‐Bestel France

D. Malcolm Duckworth

437 ×1.2

342 ×1.1

CMN

116 ×0.8

55 ×1.1

PHYSI

48 ×1.1

CTM

Citations per year, relative to D. Malcolm Duckworth D. Malcolm Duckworth (= 1×) peers Isabelle Berque‐Bestel

Countries citing papers authored by D. Malcolm Duckworth

Since Specialization

Citations

This map shows the geographic impact of D. Malcolm Duckworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Malcolm Duckworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Malcolm Duckworth more than expected).

Fields of papers citing papers by D. Malcolm Duckworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Malcolm Duckworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Malcolm Duckworth. The network helps show where D. Malcolm Duckworth may publish in the future.

Co-authorship network of co-authors of D. Malcolm Duckworth

This figure shows the co-authorship network connecting the top 25 collaborators of D. Malcolm Duckworth. A scholar is included among the top collaborators of D. Malcolm Duckworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Malcolm Duckworth. D. Malcolm Duckworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Duckworth, D. Malcolm & Philippe Sanséau. (2002). In silico identification of novel therapeutic targets. Drug Discovery Today. 7(11). S64–S69. 10 indexed citations

Warre, Ruth, Philip D. Hayes, Andrew D. Medhurst, et al.. (2001). Kinetic modification of the α_1I subunit‐mediated T‐type Ca²⁺ channel by a human neuronal Ca²⁺ channel γ subunit. The Journal of Physiology. 533(2). 467–478. 33 indexed citations

Meadows, H.J., C.G. Chapman, D. Malcolm Duckworth, et al.. (2001). The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK. Brain Research. 892(1). 94–101. 47 indexed citations

Bromidge, Steven M., Steven Dabbs, Susannah Davies, et al.. (2000). 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents. Bioorganic & Medicinal Chemistry Letters. 10(16). 1863–1866. 16 indexed citations

Beeley, Lee J., D. Malcolm Duckworth, & Christopher Southan. (2000). The Impact of Genomics on Drug Discovery. Progress in medicinal chemistry. 37. 1–43. 11 indexed citations

Bromidge, Steven M., Susannah Davies, D. Malcolm Duckworth, et al.. (2000). 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 10(16). 1867–1870. 10 indexed citations

Lovell, Peter J., Steven M. Bromidge, Steven Dabbs, et al.. (2000). A Novel, Potent, and Selective 5-HT₇Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). Journal of Medicinal Chemistry. 43(3). 342–345. 227 indexed citations

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1999). Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists. Bioorganic & Medicinal Chemistry. 7(12). 2767–2773. 5 indexed citations

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1998). Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines. Journal of Medicinal Chemistry. 41(10). 1598–1612. 53 indexed citations

10.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1998). (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT₇Receptor Antagonist. Journal of Medicinal Chemistry. 41(5). 655–657. 86 indexed citations

11.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1997). ChemInform Abstract: Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5‐HT2C/2B Receptor Antagonists.. ChemInform. 28(14). 1 indexed citations

12.

Beeley, Lee J. & D. Malcolm Duckworth. (1996). The impact of genomics on drug design. Drug Discovery Today. 1(11). 474–480. 9 indexed citations

13.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1996). Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists. Journal of Medicinal Chemistry. 39(25). 4966–4977. 23 indexed citations

14.

Duckworth, D. Malcolm, et al.. (1996). Co-cyclizations of nitrogen-containing acetylenes induced by a nickel triphenylphosphine complex to give aminoindane, isoindoline and isoindolinone derivatives. Journal of the Chemical Society Perkin Transactions 1. 815–815. 18 indexed citations

15.

Duckworth, D. Malcolm, M. R. HARNDEN, Robert M. Perkins, & D. N. Planterose. (1991). 9-[2-(Phosphonomethoxy)alkoxy]purines, A New Series of Antiviral Acyclonucleotides. Nucleosides and Nucleotides. 10(1-3). 427–430. 10 indexed citations

16.

Brown, Richard T., D. Malcolm Duckworth, & Cid Aimbiré de Moraes Santos. (1991). Biogenetically patterned synthesis of cadambine. Tetrahedron Letters. 32(17). 1987–1990. 20 indexed citations

17.

Duckworth, D. Malcolm, M. R. HARNDEN, Robert M. Perkins, & D. N. Planterose. (1991). Antiviral 9-[2-(phosphonomethoxy)alkoxy]purines. Antiviral chemistry & chemotherapy. 2(4). 229–241. 17 indexed citations

18.

Brown, Richard T. & D. Malcolm Duckworth. (1976). C-20 configuration in adirubine. Journal of the Chemical Society Chemical Communications. 530–530. 1 indexed citations

19.

Brown, Richard T., et al.. (1976). Conversion of secologanin into elenolic acid and 18-oxayohimban alkaloids. Journal of the Chemical Society Perkin Transactions 1. 160–160. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact